Published in Maturitas on April 15, 2009
Mate choice and the origin of menopause. PLoS Comput Biol (2013) 1.47
How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell (2015) 1.34
Sex hormones modulate circulating antioxidant enzymes: impact of estrogen therapy. Redox Biol (2013) 0.94
Bilateral oophorectomy, body mass index, and mortality in U.S. women aged 40 years and older. Cancer Prev Res (Phila) (2012) 0.91
Connection between telomerase activity in PBMC and markers of inflammation and endothelial dysfunction in patients with metabolic syndrome. PLoS One (2012) 0.90
Age and sex related differences in subcortical brain iron concentrations among healthy adults. Neuroimage (2015) 0.82
Menopausal symptoms and the risk of young-onset breast cancer. Eur J Cancer (2012) 0.81
Modeling perimenopause in Sprague-Dawley rats by chemical manipulation of the transition to ovarian failure. Comp Med (2012) 0.81
Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV. AIDS (2016) 0.79
Relationship between arsenic skin lesions and the age of natural menopause. BMC Public Health (2014) 0.77
Effects of aerobic exercise on urinary estrogens and progestagens in pre and postmenopausal women. Eur J Appl Physiol (2011) 0.77
Physical activity and sex hormone levels in estradiol- and placebo-treated postmenopausal women. Menopause (2011) 0.76
Gender differences, aging and hormonal status in mucosal injury and repair. Aging Dis (2014) 0.76
Serum Calcium Increase Correlates With Worsening of Lipid Profile: An Observational Study on a Large Cohort From South Italy. Medicine (Baltimore) (2016) 0.75
Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women's Health Across the Nation. Cancer Causes Control (2016) 0.75
Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension. J Womens Health (Larchmt) (2010) 0.75
Triple-blind, placebo-controlled trial of Ginkgo biloba extract on sexual desire in postmenopausal women in Tehran. Iran J Nurs Midwifery Res (2014) 0.75
Effect of Three-year Multi-Component Exercise Training on Bone Mineral Density and Content in a Postmenopausal Woman with Osteoporosis: A Case Report. Iran J Public Health (2015) 0.75
Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial. J Bone Joint Surg Am (2012) 1.54
Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. J Pain (2010) 1.14
Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial. Obstet Gynecol (2013) 1.09
Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J (2007) 1.07
Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis. BMC Musculoskelet Disord (2010) 0.96
Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study. J Med Virol (2012) 0.95
Tolerability of different oral iron supplements: a systematic review. Curr Med Res Opin (2013) 0.93
Menopausal transition in Movima women, a Bolivian Native-American. Maturitas (2005) 0.91
Epidemiology of risk factors and symptoms associated with menopause in Spanish women. Maturitas (2008) 0.88
Metastatic cutaneous plasmacytoma presenting as a perianal giant mass. Dermatol Online J (2008) 0.84
Urban-rural differences in Spanish menopausal women. Rural Remote Health (2013) 0.83
Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study. BMC Infect Dis (2012) 0.83
Leukocytoclastic vasculitis presenting as an erythema gyratum repens--like eruption on a patient with systemic lupus erythematosus. J Am Acad Dermatol (2002) 0.83
Understanding how personality factors may influence quality of life: development and validation of the Cervantes Personality Scale. Menopause (2008) 0.83
Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial. J Clin Endocrinol Metab (2013) 0.82
Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial. J Sex Med (2008) 0.82
Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America and Europe. Eur J Contracept Reprod Health Care (2013) 0.81
Is fibromyalgia part of the climacteric syndrome? Maturitas (2012) 0.81
[Fibromyalgia and menopause. Association or coincidence?]. Ginecol Obstet Mex (2011) 0.81
Neuroprotective effects of soy phytoestrogens in the rat brain. Gynecol Endocrinol (2006) 0.80
Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish women. Cancer Biomark (2007) 0.80
Structural validity of a 16-item abridged version of the Cervantes Health-Related Quality of Life scale for menopause: the Cervantes Short-Form Scale. Menopause (2015) 0.78
Third generation SERMs: anything new? Maturitas (2010) 0.78
The prescription of hormone replacement therapy in Spain: differences between general practitioners and gynaecologists. Maturitas (2006) 0.78
Spanish post-menopausal women's viewpoints on hormone therapy. Maturitas (2006) 0.78
Gynecological care in young women: a high-risk period of life. Gynecol Endocrinol (2014) 0.77
[Management of cardiovascular risk in the peri-menopausal woman--a consensus statement of European cardiologists and gynaecologists]. Kardiol Pol (2007) 0.77
Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study. Fertil Steril (2007) 0.77
Impact of anthropometric parameters on quality of life during menopause. Fertil Steril (2008) 0.77
Do patients lie? An open interview vs. a blind questionnaire on sexuality. J Sex Med (2009) 0.76
Relevant results of the WHI study for the management of the menopause in Spain. Maturitas (2003) 0.76
Assessing osteoporosis risk factors in Spanish menopausal women. Gynecol Endocrinol (2010) 0.76
Quality of life in menopausal women: a Brazilian Portuguese version of the Cervantes Scale. ScientificWorldJournal (2012) 0.76
Available medical choices for the management of menopause. Maturitas (2005) 0.75
[General recommendations over perimenopausal transition therapy]. Ginecol Obstet Mex (2007) 0.75
[Umbilical cutaneous endometriosis associated with a large uterine myoma]. Actas Dermosifiliogr (2006) 0.75
[Inhibition of RANK-L in the pathophysiology of osteoporosis. Clinical evidences of its use]. Ginecol Obstet Mex (2013) 0.75
Practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric (2004) 0.75
Management of the a-symptomatic postmenopausal woman. Maturitas (2005) 0.75
Efficacy of ossein-hydroxyapatite complex compared with calcium carbonate to prevent bone loss: a meta-analysis. Menopause (2009) 0.75
Effect of conjugated estrogens/bazedoxifene on postmenopausal bone loss: pooled analysis of two randomized trials. Menopause (2016) 0.75
Prevention of postmenopausal bone loss by pulsed estrogen therapy: comparison with transdermal route. Maturitas (2004) 0.75
[Hyperkeratotic vascular malformations. Presentation of three cases]. Actas Dermosifiliogr (2005) 0.75
Menopause, hormones and sex: the role of the doctor. Maturitas (2009) 0.75
[Substitutive hormonal treatment guidelines and risk of endometrial cancer. Data from the Million Women Study]. Med Clin (Barc) (2005) 0.75
[Non-hormonal treatment for vasomotor symptoms during menopause: role of desvenlafaxine]. Ginecol Obstet Mex (2009) 0.75